# Study of the Safety and Efficacy of Conivaptan (Vaprisol®) to Raise Serum Sodium Levels in Patients With Severe Traumatic Brain Injury

> **NCT00930202** · PHASE1 · COMPLETED · sponsor: **University of Washington** · enrollment: 10 (estimated)

## Conditions studied

- Severe Traumatic Brain Injury

## Interventions

- **DRUG:** Conivaptan (Vaprisol)

## Key facts

- **NCT ID:** NCT00930202
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2010-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00930202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00930202, "Study of the Safety and Efficacy of Conivaptan (Vaprisol®) to Raise Serum Sodium Levels in Patients With Severe Traumatic Brain Injury". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00930202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*